COO vs EMBC: fair value comparison
The Cooper Companies, Inc. and Embecta Corp. · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, COO currently sits closer to the top of our discount ranking.
| COO | EMBC | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $53.91 | $5.25 |
| 12-month range | $60.19–$83.92 | $3.28–$14.24 |
| Sector rank | #7 of 113 Healthcare | #10 of 113 Healthcare |
| Quality grade | B | B |
| Momentum grade | — | B |
| Leverage | Low | Low |
| Margin trend | Contracting | Contracting |
| Revenue growth | Modest | Declining |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Downtrend | Downtrend |
| DCF cross-check | — | Undervalued |
| 52-week position | The bottom quarter | The bottom quarter |
Full single-stock breakdowns: COO fair value analysis · EMBC fair value analysis